Innovations

Novel suppression-replacement preclinical gene therapy study shows promise in long and short QT syndromes

0

In a new study published in Circulation: Genomics & Precision Medicine, Mayo Clinic researchers designed and developed the first suppression-replacement KCNH2 gene therapy for correcting both long QT syndrome (LQTS) and short QT syndrome (SQTS).

Need a budget-friendly laptop? This Lenovo is $99.99

Previous article

The Impact of Rising Interest Rates on Mergers and Acquisitions

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations